Compare BLCO & PECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | PECO |
|---|---|---|
| Founded | 1853 | 1991 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.0B |
| IPO Year | 2022 | 2010 |
| Metric | BLCO | PECO |
|---|---|---|
| Price | $17.25 | $38.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | $18.45 | ★ $39.71 |
| AVG Volume (30 Days) | 380.8K | ★ 668.2K |
| Earning Date | 04-29-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.26% |
| EPS Growth | N/A | ★ 74.51 |
| EPS | N/A | ★ 0.56 |
| Revenue | ★ $5,101,000,000.00 | $726,594,000.00 |
| Revenue This Year | $8.65 | $5.82 |
| Revenue Next Year | $5.59 | $3.81 |
| P/E Ratio | ★ N/A | $69.16 |
| Revenue Growth | 6.47 | ★ 9.86 |
| 52 Week Low | $13.77 | $32.98 |
| 52 Week High | $18.92 | $44.38 |
| Indicator | BLCO | PECO |
|---|---|---|
| Relative Strength Index (RSI) | 58.93 | 33.93 |
| Support Level | $16.26 | $34.67 |
| Resistance Level | $17.78 | $40.80 |
| Average True Range (ATR) | 0.42 | 0.53 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 48.20 | 6.59 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Phillips Edison & Co Inc is a real estate investment trust. The company also operates a third-party investment management business providing property management and advisory services to four unconsolidated institutional joint ventures, in which it has a partial ownership interest, and one private fund. It invests in well-occupied, grocery-anchored neighborhood and community shopping centers. It holds an integrated in-house operating platform built on a market of expertise designed to optimize property value and consistently deliver a great shopping experience.